EP3291812
INJECTABLE DEPOT FORMULATIONS
:
EP einkaleyfi: Þýðing ekki lögð inn:
5.5.2016:
1.9.2021:
16790066.1
:
4.5.2036
:
INJECTABLE DEPOT FORMULATIONS
5.5.2016
1.9.2021
:
EyePoint Pharmaceuticals US, Inc.:
400 Pleasant Street, Watertown, MA 02472, US
:
ASHTON, Paul:
Newton, MA 02460, US
:
201562157257 P:
5.5.2015:
US
:
US2016030912:
5.5.2016
:
A61K 31/44, A61P 27/02, A61K 47/10, A61K 9/08